Mark Moch

MiBA (𝗠𝗲𝗮𝗻𝗶𝗻𝗴𝗳𝘂𝗹 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 | 𝗕𝗶𝗼𝗧𝗲𝗰𝗵 𝗔𝗻𝗮𝗹𝘆𝘁𝗶𝗰𝘀) is a healthcare AI technology company on a mission to close the feedback loop between physicians, patients, and industry partners. The technology and data insights that MiBA generates will support pharmaceutical companies, research organizations, payers, biotech, health systems and providers to advance the quality of patient care. Learn more at mibanalytics.com. MiBA's sophisticated platform empowers decision-makers throughout healthcare — physicians, health systems, biopharmaceutical companies and payors — with the data and tools necessary to accelerate research, optimize risk evaluation and reduce costs, enabling more accurate diagnoses and personalized treatment plans. These capabilities are integral components of MiBA's comprehensive suite of services, reflecting its commitment to advancing healthcare insights on a broader scale. As a fast-growing nationwide data platform focused on expansion, MiBA is poised to make significant contributions to oncology care, research and treatment development. The company invites partners, healthcare professionals and the broader community to join in its journey towards harnessing the full potential of data-driven insights in the battle against cancer. For practices looking to unlock and leverage their data assets to enhance clinical efficiency and productivity or for more information about MiBA and its services, visit www.mibanalytics.com .